Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial

IF 22.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of the American College of Cardiology Pub Date : 2025-04-01 Epub Date: 2025-03-24 DOI:10.1016/j.jacc.2025.01.028
David J. Maron MD , Jonathan D. Newman MD, MPH , Rebecca Anthopolos DrPH , Ying Lu MS , Susanna Stevens MS , William E. Boden MD , Kreton Mavromatis MD , Jason Linefsky MD , Rajesh G. Nair MD, DM , Olga Bockeria MD, PhD , Gilbert Gosselin MD , Gian P. Perna MD , Elena Demchenko MD, PhD , David Foo MD , Michael D. Shapiro DO, MCR , Mary Ann Champagne CNS , Christie Ballantyne MD , Peter McCullough MD , Jose Luis Lopez-Sendon MD , Frank Rockhold PhD , Judith S. Hochman MD
{"title":"Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial","authors":"David J. Maron MD ,&nbsp;Jonathan D. Newman MD, MPH ,&nbsp;Rebecca Anthopolos DrPH ,&nbsp;Ying Lu MS ,&nbsp;Susanna Stevens MS ,&nbsp;William E. Boden MD ,&nbsp;Kreton Mavromatis MD ,&nbsp;Jason Linefsky MD ,&nbsp;Rajesh G. Nair MD, DM ,&nbsp;Olga Bockeria MD, PhD ,&nbsp;Gilbert Gosselin MD ,&nbsp;Gian P. Perna MD ,&nbsp;Elena Demchenko MD, PhD ,&nbsp;David Foo MD ,&nbsp;Michael D. Shapiro DO, MCR ,&nbsp;Mary Ann Champagne CNS ,&nbsp;Christie Ballantyne MD ,&nbsp;Peter McCullough MD ,&nbsp;Jose Luis Lopez-Sendon MD ,&nbsp;Frank Rockhold PhD ,&nbsp;Judith S. Hochman MD","doi":"10.1016/j.jacc.2025.01.028","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Guideline-directed medical therapy (GDMT) with multiple risk factor goals is recommended for patients with chronic coronary disease (CCD), yet achieving all GDMT goals is uncommon. The relative importance of these goals and timing of their attainment on cardiovascular events is uncertain.</div></div><div><h3>Objectives</h3><div>This study aims to describe the relationship between achieving specific GDMT goals, when they are achieved, and clinical outcomes.</div></div><div><h3>Methods</h3><div>This was an observational study of participants with CCD in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial. The primary outcome was cardiovascular (CV) death or myocardial infarction (MI). GDMT goals were systolic blood pressure (SBP) &lt;130 mm Hg, low-density lipoprotein cholesterol &lt;70 mg/dL, not smoking, and antiplatelet therapy. Frequency of GDMT goals met at baseline and during follow-up is described. Bayesian joint modeling for longitudinal goal status and time-to-event analyses characterized the relative importance of specific GDMT goal attainment and timing with CV death/MI.</div></div><div><h3>Results</h3><div>All 5,179 ISCHEMIA participants were included. Among 4,914 participants with complete data on all 4 GDMT goals at baseline, 386 (9%), 2,073 (42%), 1,843 (38%), and 612 (12%) met 0-1, 2, 3, and 4 GDMT goals, respectively. The 4-year cumulative event rate for CV death/MI was highest for participants who attained no GDMT goals (24.5%; 95% credible interval [CrI]: 13.5%-42.2%) and lowest for those who attained all goals at baseline and remained at goal during follow-up (8.7%; 95% CrI: 6.7%-10.9%). SBP goal attainment was associated with a significant absolute event reduction in CV death/MI (–5.1%; 95% CrI: –11.3% to –1.0%), followed by antiplatelet therapy (–11.2%; 95% CrI: –29.1% to 0.8%), achieving low-density lipoprotein cholesterol &lt;70 mg/dL (–2.0%; 95% CrI: –6.0% to 2.4%), and not smoking (–1.7%; 95% CrI: –9.3% to 4.2%). Ten millimeters of mercury lower SBP during follow-up was associated with 10% relative risk reduction of CV death/MI (RR [relative risk] = 0.90; 95% CrI: 0.82-0.98), after adjusting for other GDMT goals and baseline characteristics.</div></div><div><h3>Conclusions</h3><div>Among participants with CCD, early attainment and maintenance of GDMT goals, especially SBP, were associated with fewer cardiovascular events. Compared with no GDMT goals at target, having all 4 GDMT goals at target at baseline was associated with an absolute 16% fewer CV deaths and MIs. (ISCHEMIA [International Study of Comparative Health Effectiveness With Medical and Invasive Approaches]; <span><span>NCT01471522</span><svg><path></path></svg></span>)</div></div>","PeriodicalId":17187,"journal":{"name":"Journal of the American College of Cardiology","volume":"85 12","pages":"Pages 1317-1331"},"PeriodicalIF":22.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Cardiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0735109725003213","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Guideline-directed medical therapy (GDMT) with multiple risk factor goals is recommended for patients with chronic coronary disease (CCD), yet achieving all GDMT goals is uncommon. The relative importance of these goals and timing of their attainment on cardiovascular events is uncertain.

Objectives

This study aims to describe the relationship between achieving specific GDMT goals, when they are achieved, and clinical outcomes.

Methods

This was an observational study of participants with CCD in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial. The primary outcome was cardiovascular (CV) death or myocardial infarction (MI). GDMT goals were systolic blood pressure (SBP) <130 mm Hg, low-density lipoprotein cholesterol <70 mg/dL, not smoking, and antiplatelet therapy. Frequency of GDMT goals met at baseline and during follow-up is described. Bayesian joint modeling for longitudinal goal status and time-to-event analyses characterized the relative importance of specific GDMT goal attainment and timing with CV death/MI.

Results

All 5,179 ISCHEMIA participants were included. Among 4,914 participants with complete data on all 4 GDMT goals at baseline, 386 (9%), 2,073 (42%), 1,843 (38%), and 612 (12%) met 0-1, 2, 3, and 4 GDMT goals, respectively. The 4-year cumulative event rate for CV death/MI was highest for participants who attained no GDMT goals (24.5%; 95% credible interval [CrI]: 13.5%-42.2%) and lowest for those who attained all goals at baseline and remained at goal during follow-up (8.7%; 95% CrI: 6.7%-10.9%). SBP goal attainment was associated with a significant absolute event reduction in CV death/MI (–5.1%; 95% CrI: –11.3% to –1.0%), followed by antiplatelet therapy (–11.2%; 95% CrI: –29.1% to 0.8%), achieving low-density lipoprotein cholesterol <70 mg/dL (–2.0%; 95% CrI: –6.0% to 2.4%), and not smoking (–1.7%; 95% CrI: –9.3% to 4.2%). Ten millimeters of mercury lower SBP during follow-up was associated with 10% relative risk reduction of CV death/MI (RR [relative risk] = 0.90; 95% CrI: 0.82-0.98), after adjusting for other GDMT goals and baseline characteristics.

Conclusions

Among participants with CCD, early attainment and maintenance of GDMT goals, especially SBP, were associated with fewer cardiovascular events. Compared with no GDMT goals at target, having all 4 GDMT goals at target at baseline was associated with an absolute 16% fewer CV deaths and MIs. (ISCHEMIA [International Study of Comparative Health Effectiveness With Medical and Invasive Approaches]; NCT01471522)

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
指南指导的药物治疗和缺血试验的结果
背景:对于慢性冠状动脉疾病(CCD)患者,推荐采用具有多个危险因素目标的指南导向药物治疗(GDMT),但实现所有GDMT目标并不常见。这些目标的相对重要性及其实现时间对心血管事件的影响尚不确定。本研究旨在描述实现特定GDMT目标和临床结果之间的关系。方法:本研究是一项观察性研究,在缺血(医学和侵入性方法的比较健康有效性国际研究)试验中对CCD患者进行研究。主要结局为心血管(CV)死亡或心肌梗死(MI)。GDMT的目标是收缩压130毫米汞柱,低密度脂蛋白胆固醇70毫克/分升,不吸烟,抗血小板治疗。描述在基线和随访期间实现GDMT目标的频率。纵向目标状态和事件时间分析的贝叶斯联合模型表征了特定GDMT目标实现和时间与CV死亡/MI的相对重要性。结果5179例缺血患者全部纳入。在4,914名具有基线全部4个GDMT目标完整数据的参与者中,分别有386名(9%)、2,073名(42%)、1,843名(38%)和612名(12%)达到了0- 1,2,3和4个GDMT目标。未达到GDMT目标的参与者的CV死亡/MI的4年累积事件率最高(24.5%;95%可信区间[CrI]: 13.5%-42.2%),基线时达到所有目标并在随访期间保持目标的患者最低(8.7%;95% CrI: 6.7%-10.9%)。收缩压目标的实现与CV死亡/MI绝对事件的显著减少相关(-5.1%;95% CrI: -11.3%至-1.0%),其次是抗血小板治疗(-11.2%;95% CrI: -29.1%至0.8%),实现低密度脂蛋白胆固醇<;70 mg/dL (-2.0%;95% CrI: -6.0%至2.4%),不吸烟(-1.7%;95% CrI: -9.3%至4.2%)。随访期间收缩压降低10毫米汞柱与CV死亡/MI相对风险降低10%相关(RR[相对风险]= 0.90;95% CrI: 0.82-0.98),在调整其他GDMT目标和基线特征后。结论:在CCD患者中,早期达到和维持GDMT目标,特别是收缩压,与更少的心血管事件相关。与未达到GDMT目标的患者相比,在基线时达到所有4个GDMT目标与CV死亡和MIs绝对减少16%相关。缺血[医学和侵入性方法的比较健康效果的国际研究];NCT01471522)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
42.70
自引率
3.30%
发文量
5097
审稿时长
2-4 weeks
期刊介绍: The Journal of the American College of Cardiology (JACC) publishes peer-reviewed articles highlighting all aspects of cardiovascular disease, including original clinical studies, experimental investigations with clear clinical relevance, state-of-the-art papers and viewpoints. Content Profile: -Original Investigations -JACC State-of-the-Art Reviews -JACC Review Topics of the Week -Guidelines & Clinical Documents -JACC Guideline Comparisons -JACC Scientific Expert Panels -Cardiovascular Medicine & Society -Editorial Comments (accompanying every Original Investigation) -Research Letters -Fellows-in-Training/Early Career Professional Pages -Editor’s Pages from the Editor-in-Chief or other invited thought leaders
期刊最新文献
African Representation in Randomized Controlled Trials Published in Leading Medical and Cardiovascular Journals, 2019-2024. Atrial Functional Mitral Regurgitation: Effect of Phenotype Definition on Classification, Valve Features, and Prognosis. Together at the Heart of Progress: A Joint Vision for Collaboration and Excellence in Cardiovascular Care. Clonal Hematopoiesis of Indeterminate Potential and Risk of Degenerative Valvular Heart Diseases. 2026 Dyslipidemia Guideline-at-a-Glance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1